According to ARS, the FDA regulators decided at the time that more data was needed to evaluate the safety of repeated doses of the nasal spray before it could be approved. "Neffy is epinephrine ...

the single-dose nasal spray is designed to be administered into one nostril, and was approved for use in adults and kids who weigh at least 66 pounds with severe allergies. Related: FDA approves ...

The device could upend treatment for the 33 million to 45 million Americans with severe allergies to food and other triggers.

FDA officials say this is the first epinephrine product for anaphylaxis that is not administered with a needle.

The US Food and Drug Administration (FDA) has approved the first nasal medicine to treat severe allergies. On 9 August, US health officials approved the first nasal spray to treat allergic ...

a director for the FDA’s Center for Drug Evaluation and Research. Neffy is a single-dose nasal spray approved by drugmaker ARS Pharmaceuticals Inc. that administers epinephrine, the only life ...

U.S. health officials on Friday approved a nasal spray to treat severe ... She said, “we are over the moon” about the FDA’s approval of the spray, which Zacky will start carrying when ...